Literature DB >> 8149674

Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria.

P H Jakobsen1, S Morris-Jones, T G Theander, L Hviid, M B Hansen, K Bendtzen, R G Ridley, B M Greenwood.   

Abstract

Plasma samples from children with mild and severe Plasmodium falciparum malaria and from children with unrelated diseases were collected to investigate whether the clinical outcome of infection was associated with plasma factors which reflected the activity of different cells of the immune system. Children with severe P. falciparum malaria had significantly higher plasma levels of soluble IL-2R than children with mild malaria. Plasma levels of IL-2R and levels of parasitaemia were significantly correlated. Neither parasitaemia nor plasma levels of tumour necrosis factor-alpha (TNF-alpha), IL-6, lymphotoxin (LT), interferon-gamma (IFN-gamma), IL-4, soluble IL-4R or soluble CD8 differed significantly between the two groups of children with malaria. High plasma levels of soluble CD8 were associated with failure of lymphocytes to produce IFN-gamma in vitro following stimulation with P. falciparum antigen. We conclude that soluble IL-2R is a useful marker of disease severity independently of the association with levels of parasitaemia, and that functional regulation of different lymphocyte subsets occurs during acute malaria episodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149674      PMCID: PMC1534535          DOI: 10.1111/j.1365-2249.1994.tb06237.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.

Authors:  G E Grau; P F Piguet; H D Engers; J A Louis; P Vassalli; P H Lambert
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  Increased levels of released interleukin-2 receptors in Plasmodium falciparum malaria.

Authors:  P Nguyen-Dinh; A E Greenberg
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

3.  In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.

Authors:  M T Lotze; M C Custer; S O Sharrow; L A Rubin; D L Nelson; S A Rosenberg
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

4.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor.

Authors:  G E Grau; H Heremans; P F Piguet; P Pointaire; P H Lambert; A Billiau; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  The role of TH1 and TH2 cells in a rodent malaria infection.

Authors:  A W Taylor-Robinson; R S Phillips; A Severn; S Moncada; F Y Liew
Journal:  Science       Date:  1993-06-25       Impact factor: 47.728

6.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.

Authors:  G E Grau; L F Fajardo; P F Piguet; B Allet; P H Lambert; P Vassalli
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

7.  In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

Authors:  M T Lotze; L W Frana; S O Sharrow; R J Robb; S A Rosenberg
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  CD8+ T cells inhibit Plasmodium falciparum-induced lymphoproliferation and gamma interferon production in cell preparations from some malaria-immune individuals.

Authors:  E M Riley; O Jobe; H C Whittle
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line.

Authors:  D A Brake; C A Long; W P Weidanz
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

10.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

View more
  10 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria.

Authors:  L Hviid; J A Kurtzhals; B Q Goka; J O Oliver-Commey; F K Nkrumah; T G Theander
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Immunization with Recombinant Plasmodium falciparum Erythrocyte Membrane Protein 1 CIDRα1 Domains Induces Domain Subtype Inhibitory Antibodies.

Authors:  Louise Turner; Thor G Theander; Thomas Lavstsen
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

4.  Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.

Authors:  John M Ong'echa; Gregory C Davenport; John M Vulule; James B Hittner; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

5.  A systematic review and meta-analysis of blood interleukin-4 levels concerning malaria infection and severity.

Authors:  Kwuntida Uthaisar Kotepui; Phiman Thirarattanasunthon; Pongruj Rattaprasert; Manas Kotepui
Journal:  Malar J       Date:  2022-07-12       Impact factor: 3.469

6.  Plasmodium falciparum induces apoptosis in human mononuclear cells.

Authors:  A Toure-Balde; J L Sarthou; G Aribot; P Michel; J F Trape; C Rogier; C Roussilhon
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Malaria associated apoptosis is not significantly correlated with either parasitemia or the number of previous malaria attacks.

Authors:  Evelyn K P Riccio; Ivan Neves Júnior; Lilian R Pratt Riccio; Maria das Graças Alecrim; Suzana Corte-Real; Mariza Morgado; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

8.  Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.

Authors:  P H Jakobsen; S Morris-Jones; A Rønn; L Hviid; T G Theander; I M Elhassan; I C Bygbjerg; B M Greenwood
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

9.  Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites.

Authors:  M Waterfall; A Black; E Riley
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

10.  Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults.

Authors:  Yakhya Dieye; Babacar Mbengue; Shobha Dagamajalu; Mouhamadou Mansour Fall; Mun Fai Loke; Cheikh Momar Nguer; Alassane Thiam; Jamuna Vadivelu; Alioune Dieye
Journal:  PeerJ       Date:  2016-05-02       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.